
Work Here?
Pathfinder develops a rigidizing overtube to improve endoscope control during gastrointestinal (GI) procedures. It addresses endoscope looping by allowing the overtube to instantly switch from flexible to rigid, stabilizing the endoscope and making navigation easier in complex cases and altered anatomy. The product works by being placed over the endoscope during a procedure; in flexible mode it slides with the scope, and when rigidity is needed, it becomes stiff to prevent looping, guiding the scope more precisely. Pathfinder differentiates itself from competitors by offering a quick toggle between flexible and rigid states, focusing specifically on GI procedures such as luminal therapeutics and ERCP, and targeting improved procedural efficiency and success rates in hospitals and clinics. The company aims to improve procedural outcomes, shorten procedure times, and enhance patient care by providing a reliable solution to endoscope looping that supports clinicians in difficult cases.
Industries
Healthcare
Company Size
51-200
Company Stage
Series D
Total Funding
$97M
Headquarters
Burlingame, California
Founded
2016
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$97M
Above
Industry Average
Funded Over
1 Rounds
Industry standards
Health Insurance
Paid Vacation
Paid Holidays
Flexible Work Hours
Remote Work Options
401(k) Retirement Plan
401(k) Company Match
Professional Development Budget
Conference Attendance Budget
Stock Options
Company Equity
Wellness Program
Mental Health Support
Gym Membership
Phone/Internet Stipend
Home Office Stipend
Family Planning Benefits
Fertility Treatment Support
Parental Leave
Adoption Assistance
Childcare Support
Relocation Assistance
Employee Referral Bonus
Performance Bonus
Listen to this articleSwiss-Mile raised $22M in August 2024 for its wheeled quadruped. Fifty producers of robots and robotics enabling technologies received funding in August 2024, pulling in a total of approximately $1 billion. This figure is on par with the $1.2 billion average The Robot Report has tracked each of the previous 12 months. Investment targeted to robotics companies for the first eight months of 2024 equals about $10.86 billion. You can follow The Robot Report‘s investment section here. The largest investments in August were secured by developers of autonomous driving technologies
Neptune Medical announces $97 million in Series D financing, along with the spinout of its Jupiter Endovascular subsidiary.
Find jobs on Simplify and start your career today
Industries
Healthcare
Company Size
51-200
Company Stage
Series D
Total Funding
$97M
Headquarters
Burlingame, California
Founded
2016
Find jobs on Simplify and start your career today